午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Guangzhou Viocon Pharmaceutical Technology Co., Ltd

Guangzhou Viocon Pharmaceutical Technology Co., Ltd

Current Location: HOME >> Product
Product Categories
Country: China
Tel:
Mobile: 13424074264
E-mail:
QQ:
Skype: Chat Now!
Product Name MF CAS Details
N-Nitroso desmethyl Bedaquiline Details
(R,S)-N-NITROSOANABASINE C10H13N3O 37620-20-5 Details
N-Nitroso Bendroflumethiazide Details
N-Nitroso Benzonatate Details
N-Nitroso Belumosudil Details
N-Nitroso Avacopan Details
N-Nitroso Argatroban Details
N-Nitroso Avanafil Details
N-Nitroso desmethyl Almotriptan Details
N-Nitroso tadalafil Details
2-bromo-3-methylpropiophenone C10H11BrO 1451-83-8 Details
2-(Cyclohept-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane C13H23BO2 287944-13-2 Details
Ethyl 1,4,6,7-tetrahydropyrano[4,3-c]pyrazole-3-carboxylate C9H12N2O3 518990-21-1 Details
1-methyl-1H-imidazole-5-boronic acid pinacol este C10H17BN2O2 942070-72-6 Details
Glycine, N-[(1,1-dimethylethoxy)carbonyl]-, anhydride with 2-methylpropyl hydrogen carbonate C12H21NO6 66866-43-1 Details
2-Amino-1-morpholinoethanone C6H12N2O2 56414-96-1 Details
2,6-difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline C12H16BF2NO2 939968-08-8 Details
Ruxolitinib C17H18N6 941678-49-5 Details
Crizotinib C21H22Cl2FN5O 877399-52-5 Details
Erlotinib hydrochloride C22H24ClN3O4 183319-69-9 Details
Sunitinib Malate C26H33FN4O7 341031-54-7 Details
GSK1120212 (DMSO solvate) C28H29FIN5O5S 1187431-43-1 Details
Sorafenib tosylate C21H16ClF3N4O3.C7H8O3S 475207-59-1 Details
lenvatinib Mesylate C22H23ClN4O7S 857890-39-2 Details
Ibrutinib Impurity C50H48N12O4 2417548-76-4 Details
Pomalidomide C13H11N3O4 19171-19-8 Details
Nilotinib Hydrochloride C28H23ClF3N7O 923288-95-3 Details
Dasatinib C22H26ClN7O2S 302962-49-8 Details
LenalidoMide C13H13N3O3 191732-72-6 Details
Imatinib mesylate C30H35N7O4S 220127-57-1 Details
Trametinib Impurity 03 C16H16FIN4O2 871700-30-0 Details
Trametinib Impurity 21 C24H21FIN5O3 871701-87-0 Details
Trametinib Impurity 13 C25H21FIN3O6S 871700-32-2 Details
Trametinib Impurity 11 C26H23FIN5O4 871700-25-3 Details
Dasatinib Impurity 1 Details
Crizotinib Impurity10 C21H22Cl2FN5O 1374356-45-2 Details
Crizotinib Impurity 04 C16H13Cl2FN4O 3026867-46-6 Details
Crizotinib Impurity 03 C21H23ClFN5O 1801651-84-2 Details
Ruxolitinib Impurity4 C18H20N6O 41685-37-6 Details
Palbociclib Impurity C22H28ClN7O Details
Ruxolitinib Impurity2 Details
1-(2-Hydroxyethyl)piperazine C6H14N2O 103-76-4 Details
Atrasentan Impurity 05 Details
Atrasentan Impurity 04 Details
Atrasentan Impurity 07 Details
Ibubinib impurity 06 C24H24N6O2 1288338-95-3 Details
Ibubinib impurity 04 C50H48N12O4 2031255-23-7 Details
Ibubinib impurity 02 C25H24N6O2 936563-96-1 Details
Ibubinib impurity 03 C47H46N12O3 1987905-93-0 Details
Ibubinib impurity 08 C26H28N6O3 2031255-26-0 Details
Ibubinib impurity 12 C25H24N6O2 936563-92-7 Details
Ibubinib impurity 07 C25H26N6O2 1839099-22-7 Details
Palbociclib Impurity02 C22H26BrN7O 851067-56-6 Details
Palbociclib Impurity03 C25H29N7O3 2174002-16-3 Details
Palbociclib Impurity04 C15H18N4O2 571189-64-5 Details
Palbociclib Impurity1 C36H28O3P2 808142-23-6 Details
Palbociclib Impurity05 C27H35N7O3 571189-65-6 Details
Palbociclib Impurit 01 C22H27N7O 571190-22-2 Details
Ruxolitinib Impurity 30 C16H18N6O 2606144-45-8 Details
Palbociclib Impurity08 C14H22N4O2 1023594-49-1 Details
Palbociclib Impurity07 C13H13Br2N3O 1415560-29-0 Details
Palbociclib Impurity12 C13H14BrN3O2 1922954-32-2 Details
Ruxolitinib Impurity 01 C9H7N5 952518-97-7 Details
Palbociclib Impurity14 C29H37N7O3 1941177-45-2 Details
Ruxolitinib Impurity 02 C16H18N6O2 2606144-44-7 Details
Dasatinib Impurity10 C16H13Cl2N5OS 302964-08-5 Details
Dasatinib Impurity09 C11H10ClN3OS 302964-24-5 Details
Dasatinib Impurity08 C22H27N7O2S 1184919-23-0 Details
Ruxolitinib Impurity 04 C17H20N6O 1911644-32-0 Details
Ruxolitinib Impurity 06 C25H29N7 3027185-21-0 Details
Ruxolitinib Impurity10 C25H18ClN3 1792190-52-3 Details
Ruxolitinib Impurity 05 C17H19N5O2 2102675-40-9 Details
Dasatinib Impurity03 C36H34Cl2N12O2S2 910297-61-9 Details
Dasatinib Impurity02 C22H26ClN7O3S 910297-52-8 Details
Dasatinib Impurity12 C5H4Cl2N2 1780-26-3 Details
Dasatinib Impurity01 C20H22ClN7OS 910297-51-7 Details
Dasatinib Impurity11 C12H14ClNO2 863127-76-8 Details
N-Nitroso Acebutolol Details
N-Nitroso desmethyl Amitriptyline C19H20N2O 55855-42-0 Details
Dasatinib Impurity07 C15H20N6O3S 1245157-42-9 Details
Crizotinib Impurity09 C23H26Cl2FN5O 1428476-77-0 Details
Trametinib Impurity 17 C26H24FN5O4 871700-65-1 Details
N-Nitroso Albuterol C13H20N2O4 2919946-71-5 Details
Dasatinib Impurity04 C18H24ClN5O 2099694-53-6 Details
Ruxolitinib Impurity12 3016399-18-8 Details
Palbociclib Impurity11 C16H24N4O3 1311611-88-7 Details
Atrasentan Impurity 01 C29H38N2O6 Details
Atrasentan Impurity 03 Details
Trametinib Impurity 19 C17H17FIN3O3 3018911-27-5 Details
Trametinib Impurity 15 C15H16N2O3S 329941-39-1 Details
tert-Butyl (2-oxo-2-((2,2,2-trifluoroethyl)amino)ethyl)carbamate C9H15F3N2O3 1231755-15-9 Details
Ruxolitinib Impurity11 2231734-31-7 Details
Ruxolitinib Impurity 08 C17H18N6.H3O4P 2703484-89-1 Details
Palbociclib Impurity09 C14H18N6 2144748-14-9 Details
Benzenebutanoic acid, γ-cyano-3,4-dimethoxy-γ-(1-methylethyl)-, (γS)-, compd. with (αR)-α-methylbenzenemethanamine (1:1) C16H21NO4.C8H11N 194854-18-7 Details
Palbociclib Impurity15 C24H29N7O2 2204368-66-9 Details
Crizotinib Impurity05 C23H24Cl2FN5O2 2925080-43-7 Details
Trametinib Impurity 20 C26H23FIN5O4 871701-23-4 Details
Trametinib Impurity 02 C13H11FIN3O2 871700-28-6 Details
N-Nitroso Amoxapine Details
Product Total: Product Page:
1 2 3 4